Validity of Self-Reported Drug Use Information Among Pregnant Women

Abstract

Introduction This study assesses validity of self-report for the use of major classes of illicit drugs and opioid-maintenance therapy among pregnant women at a substance abuse treatment program. Methods Analyses used data collected from 83 pregnant women in a prospective cohort study at the University of New Mexico. Study participants with a history of substance abuse were screened and, if eligible, enrolled during an early prenatal care visit. A follow-up interview was conducted shortly after delivery. Self-reported information about drug use later in pregnancy was compared with urine drug screen (UDS) results collected during the third trimester. Simple kappa (k) and prevalence-and-bias-adjusted kappa (PABAK) coefficients were calculated as the measures of agreement. Sensitivity and specificity of self-report for each drug class were estimated using UDS as the ‘gold standard’. Results The sample included a large proportion of ethnic minority (80% Hispanic/Latina and 7% American Indian) and socially disadvantaged (50% < less than high school education and 94% Medicaid-insured) pregnant women. On average, patients had 4.8 ± 3.0 urine drug screens during the third trimester. Sensitivity of self-report was low (<60%) for all classes of illicit drugs; however, marijuana and opioids demonstrated slightly higher sensitivity (57.9% and 58.3%, respectively) than other classes (<47%). Conclusions This study found substantial underreporting for all classes of illicit drugs among pregnant women in a substance abuse treatment program. Rates of underreporting are expected to be higher among the general population of pregnant women.

Risk of myocardial infarction associated with non‐steroidal anti‐inflammatory drugs: Impact of additional confounding control for variables collected from self‐reported data

“…A significant limitation of patient's reports is an issue of recall bias. A low concordance between information collected from pharmacy records and patient's reports was found in our study, as well as other studies . The gap between the event occurred and the time to recall partly affected the patient's ability to recall information.…”

Cannabis use during pregnancy: Pharmacokinetics and effects on child development

“…This approach, while commonly employed, may not provide an accurate evaluation of in utero exposure due to underreporting of drug use by pregnant women (Garg et al, 2016). Reluctance to report cannabis use is commonly linked to feelings of guilt, the fear of being arrested and concern over repercussions in child custody cases.…”

Discordant reporting of nonmedical opioid use in a nationally representative sample of US high school seniors

“…Self-report of illicit drug use compared to urinalysis typically produces good validity findings (15–19); however, specific prescription opioids used in a nonmedical manner (e.g., Vicodin, OxyContin) may be viewed differently by users as they are commonly prescribed (e.g., government approved, pharmaceutical grade pills) and thus different from other “street” drugs. Furthermore, underreporting of nonmedical opioid use has been found to be common in some populations (e.g., among pregnant women, those who are dependent, veterans, adolescents) (20–25), but underreporting may also be due, in part, to confusion regarding which drugs are opioids, or in regard to medical versus nonmedical/recreational use. A study assessing validity of using a self-report questionnaire compared to self-report via identification of specific opioids from color photographs found that validity was higher for OxyContin, but lower for generic extended-release oxycodone (ƙ = 0.62 and 0.46, respectively) when compared to some other opioids, such as methadone wafers/disks, methadone tablets, or Dilaudid (9), suggesting that reporting of use of individual types of opioids may not always be reliable.…”